Proto Labs (PRLB) is back in focus after reporting record quarterly revenue, 12.1% year over year revenue growth, and earnings that came in ahead of market expectations, along with guidance that topped EPS forecasts.
See our latest analysis for Proto Labs.
Despite the upbeat earnings news, Proto Labs has had a mixed share price run, with a 12.71% 90-day share price return and an 11.04% year-to-date share price return. The 1-year total shareholder return sits at 61.12% and the 3-year total shareholder return at 78.08%, in contrast to a 52.16% total shareholder return decline over five years. This suggests that momentum has recently improved compared with a weaker longer-term picture.
If this earnings-driven move has you looking beyond a single name, it could be a good moment to see what else is setting up in 33 robotics and automation stocks
With record revenue, faster earnings growth and the share price still sitting at a discount to analyst targets, is Proto Labs offering you an overlooked entry point, or is the market already pricing in the next phase of its growth?
Most Popular Narrative: 20.4% Undervalued
Proto Labs' most followed narrative points to a fair value of $71.67 versus the last close at $57.02, framing a sizable valuation gap that rests on specific growth drivers and margin assumptions.
Ongoing investments in sales enablement, marketing, and optimization of fulfillment channels are improving customer experience and wallet share, evidenced by higher revenue per customer (+11% y/y) and increased cross-platform adoption (+44% y/y), which points to future top-line growth and improved earnings quality.
Curious what kind of revenue base, profit margin lift, and future P/E multiple are baked into that valuation gap? The underlying narrative leans on a specific blend of growth in higher requirement manufacturing, richer customer monetization, and a premium earnings multiple that many investors usually associate with faster growing sectors.
Result: Fair Value of $71.67 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, this hinges on Europe stabilizing and key Aerospace & Defense customers sticking with Proto Labs, because sustained regional weakness or lost major accounts could quickly challenge that thesis.
Find out about the key risks to this Proto Labs narrative.
Another Angle on Value
The most followed narrative leans on earnings forecasts and a rich future P/E to argue Proto Labs is 20.4% undervalued, but the current P/E of 63.8x tells a different story. That compares with a fair ratio of 26.3x, a US Machinery industry average of 25.3x, and a peer average of 30.1x, which points to meaningful valuation risk if sentiment cools or growth expectations are revised.
With that gap on the table, it becomes a question of whether you see this premium as justified by future execution or as a margin of error that could unwind quickly.
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
With sentiment divided between premium risk and potential upside, this is a good moment to review the details yourself and move quickly to shape your own view by reviewing the 3 key rewards
Looking for more investment ideas?
If Proto Labs has sharpened your focus, do not stop here. The right mix of quality, risk, and income across other stocks could round out your next move.
- Spot potential value opportunities early by scanning 58 high quality undervalued stocks before price and sentiment fully reflect their fundamentals.
- Prioritize resilience and sleep easier at night by checking companies in the 64 resilient stocks with low risk scores that pair lower risk scores with steady profiles.
- Strengthen the core of your portfolio by reviewing the solid balance sheet and fundamentals stocks screener (39 results) so you do not miss businesses grounded in robust finances.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com